PMA device
Clarion Multi-Strategy Cochlear Implant
Advanced Bionics · Implant, Cochlear (MCM, Class III) · First FDA decision Jun 16, 2000, newest Sep 18, 2026Hearing loss
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
PMA pathway
Device trials
0
Naming "Clarion Multi-Strategy"
MAUDE reports
0
Brand "Clarion Multi-Strategy", since 2015
PubMed studies
29
Mentioning "Clarion Multi-Strategy"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Clarion Multi-Strategy Cochlear Implant
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 0 of 6 decisions filed under this name.
FDA's records could not be loaded.
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cochlear ImplantationNational analysisReview closedCAG-00107RUpdated Sep 17, 2026
- Cochlear ImplantationNational analysisReview closedCAG-00107NUpdated Sep 17, 2026
- Cochlear ImplantationNational determinationOn the books50.3Updated Mar 26, 2024
Clinical trials
Device studies on ClinicalTrials.gov that name "Clarion Multi-Strategy", any status and sponsor, newest update first.
No registered device study names "Clarion Multi-Strategy".
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Clarion Multi-Strategy", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MCM
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Clarion Multi-Strategy"[tiab]. The summary above synthesizes these.
- The CLARION Multi-Strategy Cochlear Implant.
Kessler DK · Ann Otol Rhinol Laryngol Suppl · 1999
- Cochlear implant performance in senior citizens.
Labadie RF, Carrasco VN, Gilmer CH, et al. · Otolaryngol Head Neck Surg · 2000Clinical Trial, Comparative Study
- The Clarion Multi-Strategy Cochlear Implant--surgical technique, complications, and results: a single institutional experience.
Lalwani AK, Larky JB, Wareing MJ, et al. · Am J Otol · 1998
- Surgical technique for the CLARION cochlear implant.
Balkany TJ, Cohen NL, Gantz BJ · Ann Otol Rhinol Laryngol Suppl · 1999
- Programming features of the CLARION Multi-Strategy Cochlear Implant.
Zimmerman-Phillips S, Murad C · Ann Otol Rhinol Laryngol Suppl · 1999
- Clinical results of the CLARION magnetless cochlear implant.
Weber BP, Neuburger J, Goldring JE, et al. · Ann Otol Rhinol Laryngol Suppl · 1999Clinical Trial
- Adult cochlear implant patient performance with evolving electrode technology.
Zwolan T, Kileny PR, Smith S, et al. · Otol Neurotol · 2001
- Speech perception results in children using the Clarion Multi-Strategy Cochlear Implant.
Osberger MJ, Kalberer A, Zimmerman-Phillips S, et al. · Ann Otol Rhinol Laryngol Suppl · 2000
- Speech perception results in adults implanted with the CLARION Multi-Strategy cochlear implant.
Osberger MJ, Fisher L, Kalberer A · Adv Otorhinolaryngol · 2000Comparative Study
- Speech perception results in children implanted with the CLARION Multi-Strategy cochlear implant.
Osberger MJ, Fisher L, Kalberer A · Adv Otorhinolaryngol · 2000Clinical Trial, Comparative Study
- Implantation of patients with prelingual long-term deafness.
Waltzman SB, Cohen NL · Ann Otol Rhinol Laryngol Suppl · 1999Case Reports
- Simultaneous Analog Stimulation (SAS)--Continuous Interleaved Sampler (CIS) pilot comparison study in Europe.
Battmer RD, Zilberman Y, Haake P, et al. · Ann Otol Rhinol Laryngol Suppl · 1999Clinical Trial, Comparative Study
Other devices of this type
Also filed under product code MCM.
- HiResolution Bionic Ear SystemAdvanced Bionics · PMA 2026
- Nucleus® 24 Cochlear Implant SystemCochlear Americas · PMA 2025
- COMBI 40+ Cochlear Implant SystemMed-El Corp. · PMA 2019
- Nucleus Cochlear Implant SystemsCochlear Americas · PMA 2022
- Nucleus® 22 Cochlear Implant SystemCochlear Americas · PMA 2025
- MED-EL Cochlear ImplantMed-El Corp. · PMA 2026
- Harmony Hiresolution Bionic Ear SystemAdvanced Bionics · PMA 2012
- Nucleus 24 Auditory Brainstem ImplantCochlear Americas · PMA 2003
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.